Long-term renal function in heart transplant children on cyclosporine treatment

被引:9
作者
Dello Strologo, L
Parisi, F
Legato, A
Pontesilli, C
Pastore, A
Ravà, L
Tozzi, AE
Rizzoni, G
机构
[1] Bambino Gesu Childrens Hosp & Res Inst, Div Nephrol & Dialysis, I-00165 Rome, Italy
[2] Bambino Gesu Childrens Hosp & Res Inst, Epidemiol Unit, I-00165 Rome, Italy
关键词
heart transplantation; cyclosporin A; renal function; children; nephrotoxicity;
D O I
10.1007/s00467-006-0037-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Renal function deterioration is a reason of concern in heart transplantation. Our aim was to evaluate long-term renal function in heart transplant children on cyclosporine (CsA) treatment and to investigate the effect of several variables possibly involved in renal function deterioration. Creatinine clearances were retrospectively reviewed in 50 children (median follow 99.7 months after heart transplant). Gender, age, and body weight at transplant, rejection episodes, CsA cumulative dose, and trough levels were analyzed. After an initial increase of the glomerular filtration rate (GFR), renal function worsened in most patients; 28% of the children developed renal insufficiency (defined as GFR < 80 ml/min per 1.73 m(2)), which was already evident in the first 3 years. Neither CsA dose, trough levels, nor other patient characteristics were found to be associated with renal function deterioration. In this study renal failure occurred in one-third of the patients. The lack of association of CsA with renal insufficiency may be explained by several reasons, including the limitations of the retrospective design of the study. However, it is possible that the nephrotoxic effect of CsA is more likely to occur in a set of predisposed patients. These must be soon identified to evaluate early a calcineurin inhibitor-sparing strategy.
引用
收藏
页码:561 / 565
页数:5
相关论文
共 25 条
  • [1] Aleksic I, 2000, TRANSPLANTATION, V69, P1586
  • [2] Heart transplantation in children and infants:: Short-term outcome and long-term follow-up
    Bauer, J
    Thul, J
    Krämer, U
    Hagel, KJ
    Akintürk, H
    Valeske, K
    Kreuder, J
    Schindler, E
    Bohle, RM
    Schranz, D
    [J]. PEDIATRIC TRANSPLANTATION, 2001, 5 (06) : 457 - 462
  • [3] The Registry of the International Society for Heart and Lung Transplantation: Fifth official pediatric report 2001 to 2002
    Boucek, MM
    Edwards, LB
    Keck, BM
    Trulock, EP
    Taylor, DO
    Mohacsi, PJ
    Hertz, MI
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (08) : 827 - 840
  • [4] C2 monitoring: A reliable tool in pediatric renal transplant recipients
    Dello Strologo, L
    Pontesilli, C
    Rizzoni, G
    Tozzi, AE
    [J]. TRANSPLANTATION, 2003, 76 (02) : 444 - 445
  • [5] Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level
    Dello Strologo, L
    Campagnano, P
    Federici, G
    Rizzoni, G
    [J]. PEDIATRIC NEPHROLOGY, 1999, 13 (02) : 95 - 97
  • [6] DelloStrologo L, 1996, PEDIATR NEPHROL, V10, P81
  • [7] Risk factors for chronic renal dysfunction in cardiac allograft recipients
    Esposito, C
    Semeraro, L
    Bellotti, N
    Fasoli, G
    Fornoni, A
    Rampino, T
    Klersy, C
    Campana, C
    Gavazzi, A
    Viganò, M
    Dal Canton, A
    [J]. NEPHRON, 2000, 84 (01): : 21 - 28
  • [8] Falkner B, 1996, PEDIATRICS, V98, P649
  • [9] Cyclosporine-associated end-stage nephropathy after cardiac transplantation - Incidence and progression
    Goldstein, DJ
    Zuech, N
    Sehgal, V
    Weinberg, AD
    Drusin, R
    Cohen, D
    [J]. TRANSPLANTATION, 1997, 63 (05) : 664 - 668
  • [10] Goral S, 1997, J HEART LUNG TRANSPL, V16, P1106